Shea T B, Beermann M L
Laboratories for Molecular Neuroscience, Mailman Research Center, McLean Hospital, Belmont, MA 02178.
J Neuroimmunol. 1993 Apr;44(1):117-21. doi: 10.1016/0165-5728(93)90274-3.
The monoclonal antibodies SMI-31 and SMI-34 react with phosphate-dependent epitopes of the high molecular mass (200 kDa) neurofilament protein (Hphos). Determination of whether or not these monoclonals react with different epitopes would assist in interpretation of post mortem immunocytochemical analyses in neurodegenerative disorders and in normal aging. We therefore examined the relative immunoreactivity of these antibodies against Triton-insoluble (cytoskeleton-associated) and Triton-soluble Hphos variants in NB2a/d1 neuroblastoma and post-natal mouse brain in immunoblot analysis. Densitometric analysis yielded a 'reactivity ratio' (soluble Hphos/insoluble Hphos) for each antibody. This ratio was approximately 44% and 87% less for SMI-34 than for SMI-31 in neuroblastoma and brain, respectively. These findings confirm that the SMI-34 epitope is distinct from that recognized by SMI-31, and, in these systems, is preferentially associated with the cytoskeleton.
单克隆抗体SMI - 31和SMI - 34与高分子量(200 kDa)神经丝蛋白(Hphos)的磷酸依赖性表位发生反应。确定这些单克隆抗体是否与不同表位发生反应,将有助于解释神经退行性疾病和正常衰老过程中的死后免疫细胞化学分析结果。因此,我们在免疫印迹分析中检测了这些抗体针对NB2a/d1神经母细胞瘤和新生小鼠脑中Triton不溶性(细胞骨架相关)和Triton可溶性Hphos变体的相对免疫反应性。光密度分析得出了每种抗体的“反应率”(可溶性Hphos/不溶性Hphos)。在神经母细胞瘤和脑中,SMI - 34的这一比率分别比SMI - 31低约44%和87%。这些发现证实,SMI - 34表位与SMI - 31识别的表位不同,并且在这些系统中,它优先与细胞骨架相关。